Back to Search Start Over

846 A new case series of olmsted syndrome subjects confirms EGFR activation and long term efficacity of oral erlotinib with acceptable tolerance

Authors :
J. Basset
Y. Diab
F. Santiago
L. Azulay
K. Cordoro
A. Zhang
F. Watanabe
A. Kirkorian
F. Frascari
D. Siegel
E. Bourrat
R. Howard
A. Hovnanian
Source :
Journal of Investigative Dermatology. 142:S147
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Details

ISSN :
0022202X
Volume :
142
Database :
OpenAIRE
Journal :
Journal of Investigative Dermatology
Accession number :
edsair.doi...........edb7b9401e73038d5a2ecbc3de9a77be
Full Text :
https://doi.org/10.1016/j.jid.2022.05.860